Sara Tehrani

471 total citations
16 papers, 278 citations indexed

About

Sara Tehrani is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Sara Tehrani has authored 16 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Sara Tehrani's work include Blood properties and coagulation (6 papers), Thermoregulation and physiological responses (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Sara Tehrani is often cited by papers focused on Blood properties and coagulation (6 papers), Thermoregulation and physiological responses (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Sara Tehrani collaborates with scholars based in Sweden, Austria and United Kingdom. Sara Tehrani's co-authors include Patrik Gille-Johnson, Gun Jörneskog, Fariborz Mobarrez, Jan Jakobsson, Håkan Wallén, Per‐Olof Åstrand, Per‐Eric Lins, Ulf Adamson, Aleksandra Antovič and Peter Henriksson and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and Atherosclerosis.

In The Last Decade

Sara Tehrani

14 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Tehrani Sweden	10	69	55	54	49	46	16	278
Tomo Lucijanić Croatia	9	38 0.6×	26 0.5×	40 0.7×	52 1.1×	28 0.6×	18	269
Prateek Lohia United States	9	35 0.5×	39 0.7×	53 1.0×	79 1.6×	59 1.3×	26	311
Yinghong Zhai China	8	51 0.7×	43 0.8×	26 0.5×	17 0.3×	127 2.8×	20	336
Nicola Napoli Italy	12	68 1.0×	53 1.0×	24 0.4×	14 0.3×	31 0.7×	34	386
Ali Rahimi Iran	9	89 1.3×	32 0.6×	33 0.6×	32 0.7×	104 2.3×	25	445
Vanesa Bernal Monterde Spain	11	31 0.4×	83 1.5×	20 0.4×	34 0.7×	36 0.8×	48	306
Na He China	10	23 0.3×	32 0.6×	32 0.6×	46 0.9×	54 1.2×	31	337
Sruthi Adimadhyam United States	12	19 0.3×	17 0.3×	56 1.0×	16 0.3×	44 1.0×	23	336
Lorena Vega‐Piris Spain	10	15 0.2×	52 0.9×	26 0.5×	62 1.3×	65 1.4×	21	308
Marie Fisk United Kingdom	13	44 0.6×	48 0.9×	98 1.8×	84 1.7×	26 0.6×	36	529

Countries citing papers authored by Sara Tehrani

Since Specialization

Citations

This map shows the geographic impact of Sara Tehrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Tehrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Tehrani more than expected).

Fields of papers citing papers by Sara Tehrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Tehrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Tehrani. The network helps show where Sara Tehrani may publish in the future.

Co-authorship network of co-authors of Sara Tehrani

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Tehrani. A scholar is included among the top collaborators of Sara Tehrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Tehrani. Sara Tehrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fredriksson, Ingemar, et al.. (2025). Noninvasive Bedside Approaches for Assessing Microvascular Dysfunction. Journal of Vascular Research. 62(5). 233–248.

Antoniewicz, Lukasz, Anders Blomberg, Håkan Wallén, et al.. (2023). Use of heated tobacco products (IQOS) causes an acute increase in arterial stiffness and platelet thrombus formation. Atherosclerosis. 390. 117335–117335. 16 indexed citations

Jernberg, Tomas, et al.. (2023). First Sampled High-Sensitive Cardiac Troponin T is Associated With One-Year Mortality in Sepsis Patients and 30- to 365-Day Mortality in Sepsis Survivors. The American Journal of Medicine. 136(8). 814–823.e8. 5 indexed citations

Antoniewicz, Lukasz, Anders Blomberg, Håkan Wallén, et al.. (2023). Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial. Cardiovascular Toxicology. 23(7-8). 255–264. 14 indexed citations

Tehrani, Sara & Patrik Gille-Johnson. (2021). Microvascular Dysfunction in Patients with Critical Covid-19, a Pilot Study. Shock. 56(6). 964–968. 18 indexed citations

Antoniewicz, Lukasz, Anders Blomberg, Jenny A. Bosson, et al.. (2021). Late Breaking Abstract - Brief use of heated tobacco products causes increased arterial stiffness and thrombotic activity. OA2585–OA2585.

Antoniewicz, Lukasz, Anders Blomberg, Håkan Wallén, et al.. (2021). Electronic cigarettes containing nicotine increase thrombotic activity and impair microcirculation. OA2576–OA2576. 2 indexed citations

Mobarrez, Fariborz, et al.. (2020). High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications. Thrombosis Research. 196. 78–86. 11 indexed citations

Tehrani, Sara, et al.. (2020). Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients. International Journal of Infectious Diseases. 102. 415–421. 73 indexed citations

10.

Tehrani, Sara, et al.. (2020). Skin microvascular reactivity correlates to clinical microangiopathy in type 1 diabetes: A pilot study. Diabetes and Vascular Disease Research. 17(3). 2033385886–2033385886. 9 indexed citations

11.

Mobarrez, Fariborz, et al.. (2018). Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes. Thrombosis Research. 172. 158–164. 17 indexed citations

12.

Brismar, Kerstin, et al.. (2016). High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes. Growth Hormone & IGF Research. 29. 78–82. 9 indexed citations

13.

Jörneskog, Gun, et al.. (2014). Fibrin clot properties and haemostatic function in men and women with type 1 diabetes. Thrombosis and Haemostasis. 113(2). 312–318. 11 indexed citations

14.

Tehrani, Sara, Fariborz Mobarrez, Per‐Eric Lins, et al.. (2013). Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes. Diabetes and Vascular Disease Research. 10(6). 483–488. 21 indexed citations

15.

Tehrani, Sara, Aleksandra Antovič, Fariborz Mobarrez, et al.. (2011). High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes. Diabetes Care. 35(2). 404–408. 20 indexed citations

16.

Tehrani, Sara, Fariborz Mobarrez, Aleksandra Antovič, et al.. (2010). Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thrombosis Research. 126(3). e225–e231. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact